Allos Therapeutics, Inc. Launches Peripheral T-Cell Lymphoma Website

WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced the launch of a new website,, dedicated to peripheral T-cell lymphoma (PTCL). This on-line resource is designed to provide information to patients and caregivers to aide in the understanding of PTCL. Healthcare providers will be able to utilize this resource to obtain clinical information, including staging and diagnosis.

Back to news